Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases

By Aguirre-Cruz Lucinda   Charuel Jean-Luc   Carpentier Antoine   Benyahia Baya   Delattre Jean-Yves   Musset Lucile  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 39-41

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Serum Anti-p53 Antibodies from Patients with Ovarian Cancer in China: Correlation to Clinical Parameters

By Qiu Tian   Yang Qiong   Li Xing-rong   Yang Hua   Qiu Lin-lin   Wang Li  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 563-568

Informa Healthcare

Access to resources Recommend Favorite

The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

By Gao Rui-juan  

Breast Cancer Research and Treatment, Vol. 93, Iss. 2, 2005-09 ,pp. : 111-115

Springer Publishing Company

Access to resources Recommend Favorite

Anti-idiotypic Response to Antigrowth Factor Receptor Monoclonal Antibodies

By Tosi E.   Valota O.   Canevari S.   Adobati E.   Casalini P.   Perez P.   Colnaghi M.I.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 498-505

Elsevier

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite